Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat Rev Gastroenterol Hepatol. 2022;19:153–68.
Wong VW, Wong GL, Yeung DK, et al. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol. 2014;109:589–97.
Article CAS PubMed Google Scholar
Lee Y, Hirose H, Ohneda M, et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA. 1994;91:10878–82.
Article CAS PubMed PubMed Central Google Scholar
Singh RG, Yoon HD, Wu LM, et al. Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta-analysis, and meta-regression. Metabolism. 2017;69:1–13.
Article CAS PubMed Google Scholar
Taylor R, Al-Mrabeh A, Sattar N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 2019;7:726–36.
Article CAS PubMed Google Scholar
Al-Mrabeh A, Zhyzhneuskaya SV, Peters C, et al. Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss. Cell Metab. 2020;31:233–49.
Article CAS PubMed Google Scholar
Ko J, Al-Ani Z, Long K, et al. Intra-pancreatic, liver, and skeletal muscle fat depositions in first attack of acute pancreatitis versus health. Am J Gastroenterol. 2022;117:1693–701.
Al-Ani Z, Ko J, Petrov MS. Intra-pancreatic fat deposition across the pancreatitis spectrum and the influence of gut hormones. Dig Liver Dis. 2023;55:1081–90.
Article CAS PubMed Google Scholar
Ko J, Skudder-Hill L, Priya S, et al. Associations between intra-pancreatic fat deposition, pancreas size, and pancreatic enzymes in health and after an attack of acute pancreatitis. Obes Facts. 2022;15:70–82.
Article CAS PubMed Google Scholar
Sreedhar UL, DeSouza SV, Park B, et al. A systematic review of intra-pancreatic fat deposition and pancreatic carcinogenesis. J Gastrointest Surg. 2020;24:2560–9.
Petrov MS. Fateful fat: intra-pancreatic lipids cause pancreatic cancer. Cell Rep Med. 2024;5: 101428.
Article CAS PubMed PubMed Central Google Scholar
Petrov MS. Fatty change of the pancreas: the Pandora’s box of pancreatology. Lancet Gastroenterol Hepatol. 2023;8:671–82.
Della Pepa G, Salamone D, Testa R, et al. Intrapancreatic fat deposition and nutritional treatment: the role of various dietary approaches. Nutr Rev. 2023. https://doi.org/10.1093/nutrit/nuad159. (Epub ahead of print).
Ko J, Skudder-Hill L, Tarrant C, et al. Intra-pancreatic fat deposition as a modifier of the relationship between habitual dietary fat intake and insulin resistance. Clin Nutr. 2021;40:4730–7.
Article CAS PubMed Google Scholar
Ko J, Kimita W, Skudder-Hill L, et al. Dietary carbohydrate intake and insulin traits in individuals after acute pancreatitis: effect modification by intra-pancreatic fat deposition. Pancreatology. 2021;21:353–62.
Article CAS PubMed Google Scholar
Rossi AP, Fantin F, Zamboni GA, et al. Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects. Nutr Diabetes. 2012;2: e32.
Article CAS PubMed PubMed Central Google Scholar
Honka H, Koffert J, Hannukainen JC, et al. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J Clin Endocrinol Metab. 2015;100:2015–23.
Article CAS PubMed Google Scholar
Umemura A, Sasaki A, Nitta H, et al. Pancreas volume reduction and metabolic effects in Japanese patients with severe obesity following laparoscopic sleeve gastrectomy. Endocr J. 2017;64:487–98.
Article CAS PubMed Google Scholar
Lautenbach A, Wernecke M, Riedel N, et al. Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss. Diabetes Metab Res Rev. 2018;34: e3025.
Article CAS PubMed Google Scholar
Gaborit B, Abdesselam I, Kober F, et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes. 2015;39:480–7.
Hui SC, Wong SK, Ai Q, Yeung DK, Ng EK, Chu WC. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: evaluation with MRI. Eur Radiol. 2019;29:849–56.
Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care. 2016;39:808–15.
Article CAS PubMed Google Scholar
Steven S, Hollingsworth KG, Small PK, et al. Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care. 2016;39:158–65.
Article CAS PubMed Google Scholar
Goodarzi MO, Petrov MS. Diabetes of the exocrine pancreas: implications for pharmacological management. Drugs. 2023;83:1077–90.
Article CAS PubMed PubMed Central Google Scholar
Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23:201–29.
Article CAS PubMed Google Scholar
Souza-Mello V, Gregório BM, Cardoso-de-Lemos FS, et al. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin Sci (Lond). 2010;119:239–50.
Article CAS PubMed Google Scholar
Zsóri G, Illés D, Ivány E, et al. In new-onset diabetes mellitus, metformin reduces fat accumulation in the liver, but not in the pancreas or pericardium. Metab Syndr Relat Disord. 2019;17:289–95.
Kuriyama T, Ishibashi C, Kozawa J, et al. Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes. Clin Nutr ESPEN. 2024;59:208–13.
Higa M, Zhou YT, Ravazzola M, et al. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA. 1999;96:11513–8.
Article CAS PubMed PubMed Central Google Scholar
Yu X, McCorkle S, Wang M, et al. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia. 2004;47:2012–21.
Article CAS PubMed Google Scholar
Fernandes-Santos C, Evangelista Carneiro R, de Souza ML, et al. Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas. 2009;38:e80–6.
Article CAS PubMed Google Scholar
Lingvay I, Poduri M, Szczepaniak E, et al. Pioglitazone: effect on pancreatic steatosis and beta cell function. Diabetologia. 2012;55(Suppl 1):S327.
Lingvay I. Pioglitazone on pancreatic steatosis and bone health. https://clinicaltrials.gov. Accessed 18 Jan 2024.
Fang T, Huang S, Chen Y, et al. Glucagon like peptide-1 receptor agonists alter pancreatic and hepatic histology and regulation of endoplasmic reticulum stress in high-fat diet mouse model. Exp Clin Endocrinol Diabetes. 2021;129:625–33.
Article CAS PubMed Google Scholar
Kuchay MS, Krishan S, Mishra SK, et al. Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia. 2020;63:2434–45.
Article CAS PubMed Google Scholar
Dutour A, Abdesselam I, Ancel P, et al. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Diabetes Obes Metab. 2016;18:882–91.
Article CAS PubMed Google Scholar
Smits MM, Tonneijck L, Muskiet MH, et al. Pancreatic effects of liraglutide or sitagliptin in overweight patients with type 2 diabetes: a 12-week randomized, placebo-controlled trial. Diabetes Care. 2017;40:301–8.
Article CAS PubMed Google Scholar
Vanderheiden A, Harrison LB, Warshauer JT, et al. Mechanisms of action of liraglutide in patients with type 2 diabetes treated with high-dose insulin. J Clin Endocrinol Metab. 2016;101:1798–806.
Comments (0)